The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease.
Sulaiman AlalawiFaizah AlbalawiDipak P RamjiPublished in: International journal of molecular sciences (2023)
Atherosclerotic cardiovascular disease (ACVD) is the leading cause of death worldwide. Although current therapies, such as statins, have led to a marked reduction in morbidity and mortality from ACVD, they are associated with considerable residual risk for the disease together with various adverse side effects. Natural compounds are generally well-tolerated; a major recent goal has been to harness their full potential in the prevention and treatment of ACVD, either alone or together with existing pharmacotherapies. Punicalagin (PC) is the main polyphenol present in pomegranates and pomegranate juice and demonstrates many beneficial actions, including anti-inflammatory, antioxidant, and anti-atherogenic properties. The objective of this review is to inform on our current understanding of the pathogenesis of ACVD and the potential mechanisms underlying the beneficial actions of PC and its metabolites in the disease, including the attenuation of dyslipidemia, oxidative stress, endothelial cell dysfunction, foam cell formation, and inflammation mediated by cytokines and immune cells together with the regulation of proliferation and migration of vascular smooth muscle cells. Some of the anti-inflammatory and antioxidant properties of PC and its metabolites are due to their strong radical-scavenging activities. PC and its metabolites also inhibit the risk factors of atherosclerosis, including hyperlipidemia, diabetes mellitus, inflammation, hypertension, obesity, and non-alcoholic fatty liver disease. Despite the promising findings that have emerged from numerous in vitro, in vivo, and clinical studies, deeper mechanistic insights and large clinical trials are required to harness the full potential of PC and its metabolites in the prevention and treatment of ACVD.
Keyphrases
- oxidative stress
- anti inflammatory
- cardiovascular disease
- ms ms
- vascular smooth muscle cells
- clinical trial
- risk factors
- blood pressure
- type diabetes
- ischemia reperfusion injury
- angiotensin ii
- insulin resistance
- diabetic rats
- metabolic syndrome
- high fat diet
- weight loss
- randomized controlled trial
- adipose tissue
- single cell
- weight gain
- body mass index
- cell therapy
- stem cells
- coronary artery disease
- skeletal muscle
- risk assessment
- cardiovascular risk factors